Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells

Molecular Biology Reports

Volumn 34, Issue 4, 2007, Pages 221-224

  Kurer, M A ^a  

^a YORK HOSPITAL   (United Kingdom)

Author keywords

Cancer cells; Lipoprotein associated coagulation inhibitor (LACI); Tissue factor pathway inhibitor (TFPI); Tissue factor pathway inhibitor type 1 (TFPI 1)

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTICOAGULATION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOPROTEINS; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 35448936006     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-006-9036-4     Document Type: Article

References (22)

1. Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, Bajaj SP (1990) Cultured normal human hepatocytes do not synthesise lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA 87:8869-8873
2. Rana SV, Reimers HJ, Pathikonda MS, Bajaj SP (1988) Expression of tissue factor and factor VIIa/tissue factor inhibitor activity in endotoxin or phorbol ester stimulated U937 monocyte-like cells. Blood 71:259-262
3. Ameri A, Kuppuswamy MN, Basu S, Bajaj SP (1992) Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood 79:3219-3226
4. Osterud B, Bajaj MS, Bajaj SP (1995) Sites of tissue factor pathway inhibitor and tissue factor expression under physiologic and pathological conditions. Thromb Haemost 73:873-875
5. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP (1988) The lipoprotein-associated coagulation inhibitor that inhibits factor VII-TF complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 71:335-343
6. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ Jr (1988) Cloning and characterisation of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 263:6001-6004
7. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ Jr (1989) Functional significance of Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338:518-520
8. Murray JC (1983) Coagulation and cancer. Br J Cancer 64:14-31
9. Rao LMV (1992) Tissue factor as a tumour procoagulant. Cancer Metastasis Rev 11:249-266
10. Gordon SG (1992) Cancer cell procoagulants and their role in malignant disease. Semin Thromb Haemost 18:424-433
11. Costantini V, Zacharaski LR (1993) Fibrin and cancer. Thromb Haemost 69:406-414
12. Kakkar AK, Chinswangwatanakul V, Lemoine NR, Tebbutt S, Williamson RC (1999) Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma. Br J Surg 86:890-894
13. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM et al (2004) Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64(15):5270-5282
14. Kakkar AK, Hedges AR, Williamson RCN, Kakkar VV (1995) Perioperative heparin therapy inhibits late death from metastatic cancer. Int J Oncol 6:885-888
15. Kingston RD, Fielding JWL, Palmer MK (1993) Peri-operative heparin. A possible adjuvant to surgery in colorectal cancer? Int J Colorectal Dis 8:111-115
16. Kohanna FH, Sweeney J, Hussey S, Zacharski LR, Salzman EW (1983) Effect of peri-operative low-dose heparin administration on the course of colon cancer. Surgery 93:433-438
17. Lebeau B, Chastang C, Berchot JM (1994) Subcutaneous heparin treatment increases survival in small cell lung cancer. Cancer 74:38-45
18. Iochmann S, Reverdiau-Moalic P, Beaujean S, Rideau E, Lebranchu Y, Bardos P, Gruel Y (1999) Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription polymerase chain reaction. Thromb Res 94:165-173
19. Kataoka H, Uchno H, Asada Y, Hatakeyama K, Nabeshima K, Sumiyoshi A, Koono M (1997) Analysis of TF and TFPI expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int J Cancer 72:878-884
20. Kakkar AK, Chinswangwatanakul V, Tebbutt S, Lemoine NR, Williamson RC (1998) A characterisation of the coagulant and fibrinolytic profile of human pancreatic carcinoma cells. Haemostasis 28:1-6
21. Werling RW, Zacharski LR, Kisiel W, Bajaj SP, Memoli VA, Rousseau SM (1993) Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost 69:366-369
22. Gyorffy B, Surowiak P, Kiesslich O, Denkert C, Schafer R, Dietel M, Lage H (2006) Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer 118(7):1699-1712